| |
|
|
|
BioCryst Pharmaceuticals Inc.  
|
|
8.21 0.34 (0.04%) |
11-19 16:00 |
|
Open: |
7.91 |
Pre close: |
7.87 |
Target:
|
9.71
|
|
High: |
8.29 |
Low: |
7.75 |
Resistance:
|
8.31
9.71
|
|
Volume: |
760,178 |
Market Cap: |
900M |
Support:
|
7.20
6.51
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.50
 |
MACD |
MACD(12,26):
|
0.15 |
|
MA(20): |
7.41 |
Signal(12,26,9): |
0.12 |
|
MA(100): |
6.89 |
Stochastic Oscillator |
%K(14,3):
|
68.83 |
|
MA(250): |
5.91 |
%D(3): |
49.19 |
|
Average Volume(K) |
3-Month: |
52312
|
52-Week |
High:
|
8.31 |
|
10-Days: |
63528 |
Low: |
4.25 |
|
RSI |
RSI(14):
|
62.18 |
Change(%): |
81.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.930 |
Return on Equity (ttm) |
-107.6 |
Shares Out. (M) |
109.64 |
|
EPS Est. Current Year |
-0.750 |
Return on Assets (ttm) |
-51.9 |
Shares Float (M) |
105.55 |
|
EPS Est. Next Year |
-0.780 |
PEG Ratio |
-0.38 |
% Held by Insiders |
4.10 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
-83.4 |
% Held by Institutions |
67.90 |
|
Forward EPS |
-0.900 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
11.000 |
EBITDA (p.s.) |
0.000 |
P/E |
-8.83 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.75 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-79.10 |
P/S |
4091565568.00 |
|
Operating Margin |
-348.95 |
Levered Free Cash Flow
(M) |
-39.17 |
P/CF |
-11.38 |
|
|
|
|
|
|
